Anish Suri

Insider Reports History

Location
Boston, MA
Signature
/s/ Anish Suri by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anish Suri:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. PRESIDENT AND CSO Common Stock 135,638 $374,361 $2.76 25 Aug 2023 Direct
Cue Biopharma, Inc. PRESIDENT AND CSO Stock Option (right to buy) 150,000 05 Jun 2024 Direct

Insider Reports Filed by Anish Suri

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 05 Jun 2024 1 $0 4 PRESIDENT AND CSO 07 Jun 2024, 16:00
CUE Cue Biopharma, Inc. 06 Mar 2024 1 $0 4 PRESIDENT AND CSO 08 Mar 2024, 16:00
CUE Cue Biopharma, Inc. 25 Aug 2023 1 +$11,040 4 PRESIDENT AND CSO 29 Aug 2023, 17:08
CUE Cue Biopharma, Inc. 21 Jul 2023 1 $0 4 PRESIDENT AND CSO 25 Jul 2023, 12:25
CUE Cue Biopharma, Inc. 16 Feb 2023 1 $0 4 PRESIDENT AND CSO 21 Feb 2023, 16:01
CUE Cue Biopharma, Inc. 31 Mar 2022 3 -$34,492 4 PRESIDENT AND CSO 04 Apr 2022, 17:31
CUE Cue Biopharma, Inc. 09 Feb 2022 2 $0 4 PRESIDENT AND CSO 29 Mar 2022, 16:15
CUE Cue Biopharma, Inc. 15 Nov 2021 3 -$78,320 4 President and CSO 17 Nov 2021, 16:00
CUE Cue Biopharma, Inc. 11 Nov 2021 3 -$172,954 4 President and CSO 15 Nov 2021, 16:00
CUE Cue Biopharma, Inc. 03 Oct 2021 3 -$183,318 4 PRESIDENT AND CSO 08 Oct 2021, 16:00
CUE Cue Biopharma, Inc. 23 Sep 2021 3 -$176,246 4 PRESIDENT AND CSO 27 Sep 2021, 16:30